These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34884968)

  • 1. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro.
    Yu MH; Hung TW; Wang CC; Wu SW; Yang TW; Yang CY; Tseng TH; Wang CJ
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
    Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
    Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells.
    Zhang J; Zhang SD; Wang P; Guo N; Wang W; Yao LP; Yang Q; Efferth T; Jiao J; Fu YJ
    Eur J Pharmacol; 2019 Oct; 861():172618. PubMed ID: 31430456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mulberry Leaf (
    Yang TY; Yu MH; Wu YL; Hong CC; Chen CS; Chan KC; Wang CJ
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
    Li N; Yin L; Shang J; Liang M; Liu Z; Yang H; Qiang G; Du G; Yang X
    Biomed Pharmacother; 2023 Sep; 165():115113. PubMed ID: 37418974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
    Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
    Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
    Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ
    J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
    Simão AL; Afonso MB; Rodrigues PM; Gama-Carvalho M; Machado MV; Cortez-Pinto H; Rodrigues CMP; Castro RE
    J Mol Med (Berl); 2019 Aug; 97(8):1113-1126. PubMed ID: 31139863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis.
    BinMowyna MN; AlFaris NA; Al-Sanea EA; AlTamimi JZ; Aldayel TS
    Arch Physiol Biochem; 2024 Jun; 130(3):300-315. PubMed ID: 35254877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Caffeoylquinic acid decreases diet-induced obesity in rats by modulating PPARα and LXRα transcription.
    Huang K; Liang XC; Zhong YL; He WY; Wang Z
    J Sci Food Agric; 2015 Jul; 95(9):1903-10. PubMed ID: 25186103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
    Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
    J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.
    Li X; Lian F; Liu C; Hu KQ; Wang XD
    Sci Rep; 2015 Nov; 5():16774. PubMed ID: 26608583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.